| US Healthcare Sector Forecast to 2012 | | | | and cancer) and proposed changes in the |
| The US represents the world’s largest | | | | reimbursement process, the country will see |
| healthcare market, with an annual spending of | | | | strong demand for hospitals and hospital beds in |
| around US$ 2.24 Trillion in 2007. The growth in | | | | the next few years. In this regard, the report |
| annual spending was mainly driven by increasing | | | | provides comprehensive information of the |
| use of patent drugs, high administrative costs and | | | | number of hospital beds that will be required to |
| expensive hospital care. We believe that the | | | | meet the rising demand for hospital services. |
| market holds a great potential with several | | | | In the pharmaceutical market, our research |
| segments still remain untapped, indicating to | | | | projects that generics will register a robust |
| immense opportunities for the industry players to | | | | growth rate in the next few years on the back |
| expand their operations. According to new | | | | of government’s efforts aimed at reducing |
| research report, “US Healthcare Sector | | | | healthcare spending in the country. The medical |
| Forecast to 2012” the US healthcare spending | | | | device market is also expected to witness strong |
| is expected to grow at a CAGR of around 4% | | | | growth in the forecast period because of latest |
| during 2007-2012. ( ) | | | | technological advancements that will make |
| We have studied the US healthcare market by | | | | treatment and diagnosis simpler and effective. |
| segregating it into four major segments - Hospital | | | | Besides, the report studies the current reform |
| care, Pharmaceutical market, Medical device | | | | process and its effects on various segments of |
| market and healthcare insurance market. Each of | | | | the industry. The research study gives detailed |
| these segments has been extensively covered in | | | | statistical and analytical review of demographics, |
| the report, giving in-depth analysis of the current | | | | macroeconomic indicators, disease profile, key |
| and future market trends. Besides, our report | | | | drivers and restraints. It contains exhaustive |
| gives elaborate details of the country’s | | | | information that will help clients to draw up |
| healthcare regulatory environment. | | | | market strategies and assess opportunity areas in |
| Our report foresees that with the increasing | | | | the US healthcare market. |
| prevalence of chronic diseases (such as diabetes | | | | |